BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12911418)

  • 41. Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers.
    Wang DY; Hanotte F; De Vos C; Clement P
    Allergy; 2001 Apr; 56(4):339-43. PubMed ID: 11284803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
    Garg G; Thami GP
    J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria.
    Dubuske LM
    Allergy Asthma Proc; 2007; 28(6):724-34. PubMed ID: 18201439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.
    Bautista AP; Eisenlohr CP; Lanz MJ
    Am J Rhinol Allergy; 2011; 25(6):383-7. PubMed ID: 22185740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effectiveness of modern antihistamines for treatment of allergic rhinitis - an IPD meta-analysis of 140,853 patients.
    Mösges R; König V; Köberlein J
    Allergol Int; 2013 Jun; 62(2):215-22. PubMed ID: 23524648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis.
    Badorrek P; Dick M; Schauerte A; Hecker H; Murdoch R; Luettig B; Hohlfeld JM; Krug N
    Int J Clin Pharmacol Ther; 2009 Feb; 47(2):71-7. PubMed ID: 19203562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.
    Layton D; Wilton L; Boshier A; Cornelius V; Harris S; Shakir SA
    Drug Saf; 2006; 29(10):897-909. PubMed ID: 16970513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.
    Horak F; Zieglmayer PU; Zieglmayer R; Kavina A; Lemell P
    Br J Clin Pharmacol; 2005 Jul; 60(1):24-31. PubMed ID: 15963090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children.
    Marcucci F; Sensi LG; Abate P; Allocca G; Ugolini E; Di Cara G; Incorvaia C
    Inflamm Allergy Drug Targets; 2011 Feb; 10(1):32-8. PubMed ID: 21184653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M; Melac M; Charpentier JC; Didier A
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J; Mullol J; Valero A; Valiente R;
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients.
    Fang SY; Perng DW; Lee JY; Lin DY; Huangs CY
    Chin J Physiol; 2010 Aug; 53(4):199-207. PubMed ID: 21793329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies.
    Hair PI; Scott LJ
    Drugs; 2006; 66(7):973-96. PubMed ID: 16740020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levocetirizine modulates lymphocyte activation in patients with allergic rhinitis.
    Mahmoud F; Arifhodzic N; Haines D; Novotney L
    J Pharmacol Sci; 2008 Oct; 108(2):149-56. PubMed ID: 18946193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xyzal (levocetirizine dihydrochloride).
    Abramovits W; Gupta A
    Skinmed; 2008; 7(2):84-5. PubMed ID: 18327014
    [No Abstract]   [Full Text] [Related]  

  • 59. Selecting the optimal oral antihistamine for patients with allergic rhinitis.
    Lehman JM; Blaiss MS
    Drugs; 2006; 66(18):2309-19. PubMed ID: 17181374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving SAR symptoms with levocetirizine: evaluating active and placebo effects in pollen challenge vs. natural exposure studies.
    Boev R; Song D; Bedenbaugh A; Haeusler JM
    Curr Med Res Opin; 2011 Jan; 27(1):107-14. PubMed ID: 21091390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.